URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jason Mendler

Concepts (83)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
3
2008
409
1.580
Why?
MicroRNAs
3
2012
38
1.150
Why?
Hodgkin Disease
2
2008
152
1.100
Why?
Leukemia, Myeloid, Acute
3
2012
172
1.070
Why?
Cytogenetic Analysis
3
2012
21
0.920
Why?
Core Binding Factor Alpha 2 Subunit
1
2012
19
0.830
Why?
Gene Expression Profiling
1
2012
296
0.680
Why?
Salvage Therapy
1
2009
56
0.640
Why?
Mutation
1
2012
1183
0.540
Why?
Nurse-Patient Relations
1
2005
7
0.520
Why?
Humanism
1
2005
7
0.520
Why?
Terminal Care
1
2005
69
0.480
Why?
Disease-Free Survival
2
2012
191
0.250
Why?
Kaplan-Meier Estimate
2
2012
190
0.240
Why?
Risk Factors
2
2009
2172
0.230
Why?
Treatment Outcome
2
2009
2487
0.210
Why?
Myeloid-Lymphoid Leukemia Protein
1
2012
7
0.200
Why?
RNA, Neoplasm
1
2012
64
0.200
Why?
Tandem Repeat Sequences
1
2012
12
0.200
Why?
DNA Mutational Analysis
1
2012
185
0.190
Why?
Proportional Hazards Models
1
2012
398
0.190
Why?
Neoplasm Proteins
1
2012
164
0.180
Why?
Multivariate Analysis
1
2012
487
0.180
Why?
Middle Aged
4
2008
9461
0.180
Why?
Oligonucleotide Array Sequence Analysis
1
2012
278
0.180
Why?
Gene Expression Regulation, Neoplastic
1
2012
247
0.170
Why?
Disease Progression
1
2012
496
0.170
Why?
Genetic Predisposition to Disease
1
2012
306
0.170
Why?
Polymerase Chain Reaction
1
2012
586
0.170
Why?
Logistic Models
1
2012
581
0.170
Why?
Tumor Markers, Biological
1
2012
221
0.170
Why?
Phenotype
1
2012
727
0.170
Why?
Platinum Compounds
1
2009
7
0.170
Why?
Age Factors
1
2012
1060
0.160
Why?
Chemotherapy, Adjuvant
1
2009
85
0.160
Why?
Radiotherapy, Adjuvant
1
2009
72
0.160
Why?
Drug Resistance, Neoplasm
1
2009
54
0.160
Why?
Humans
7
1998
35000
0.160
Why?
Aged, 80 and over
2
2012
2423
0.160
Why?
Immunologic Factors
1
2009
69
0.150
Why?
Deoxycytidine
1
2008
26
0.150
Why?
Transplantation, Homologous
1
2009
261
0.150
Why?
Risk Assessment
1
2012
808
0.150
Why?
Boronic Acids
1
2008
25
0.150
Why?
Adult
3
2008
10906
0.150
Why?
Proteasome Endopeptidase Complex
1
2008
65
0.150
Why?
Pyrazines
1
2008
29
0.150
Why?
Young Adult
1
2012
1013
0.150
Why?
Stem Cell Transplantation
1
2009
108
0.150
Why?
Recurrence
1
2009
656
0.140
Why?
Randomized Controlled Trials as Topic
1
2009
400
0.140
Why?
Male
4
2008
18870
0.130
Why?
Aged
3
2012
6986
0.130
Why?
Anecdotes as Topic
1
2005
8
0.130
Why?
Female
4
2008
19061
0.130
Why?
Resuscitation Orders
1
2005
24
0.130
Why?
Empathy
1
2005
30
0.130
Why?
Clinical Trials as Topic
1
2009
664
0.120
Why?
Time Factors
1
2012
3047
0.120
Why?
Antibodies, Monoclonal
1
2009
725
0.120
Why?
United States
1
2012
2511
0.120
Why?
Adolescent
1
2012
4513
0.110
Why?
Communication
1
2005
245
0.110
Why?
Prognosis
2
2012
1030
0.080
Why?
G1 Phase
1
1998
51
0.070
Why?
Receptors, Antigen, T-Cell
1
1998
68
0.070
Why?
Lymphocytes
1
1998
293
0.070
Why?
F-Box Proteins
1
2012
1
0.050
Why?
Ubiquitin Thiolesterase
1
2012
11
0.050
Why?
Trisomy
1
2012
13
0.050
Why?
Apoptosis
1
1998
782
0.050
Why?
Survival Rate
1
2012
584
0.040
Why?
Gene Expression
1
2012
723
0.040
Why?
Cohort Studies
1
2012
912
0.040
Why?
Jurkat Cells
1
1998
42
0.020
Why?
Retinoblastoma Protein
1
1998
35
0.020
Why?
S Phase
1
1998
44
0.020
Why?
Cyclin-Dependent Kinases
1
1998
39
0.020
Why?
Cell Cycle
1
1998
247
0.020
Why?
Enzyme Activation
1
1998
511
0.020
Why?
Lymphocyte Activation
1
1998
407
0.020
Why?
Phosphorylation
1
1998
754
0.020
Why?
Sensitivity and Specificity
1
1998
866
0.010
Why?

Visualizations


Mendler's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department